JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Herein, we describe the clinical picture of a patient harboring both a diagnosis of JAK2-V617F-mutated PV and a diagnosis of BCR::ABL1-positive CML, and one of the few available case reports of treating such a patient with a combination of imatinib and RUX.